Literature DB >> 21136062

Recent hot topics in contrast media.

Henrik S Thomsen.   

Abstract

This editorial reviews the way in which the facts related to the safety of iodinated and gadolinium based contrast agents have emerged over the last two decades. This is especially important given their ever increasing usage in modern computed tomographic (CT) and Magnetic resonance imaging (MRI) examinations. It also provides a very useful educational resume of this complex subject.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21136062     DOI: 10.1007/s00330-010-2026-x

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  29 in total

1.  Experimental studies investigating the pathophysiology of nephrogenic systemic fibrosis; what did we learn so far?

Authors:  Sameh K Morcos
Journal:  Eur Radiol       Date:  2010-09-17       Impact factor: 5.315

2.  The biodistribution of [153Gd]Gd-labeled magnetic resonance contrast agents in a transgenic mouse model of renal failure differs greatly from control mice.

Authors:  Thaddeus J Wadas; Christopher D Sherman; Jeffrey H Miner; James R Duncan; Carolyn J Anderson
Journal:  Magn Reson Med       Date:  2010-11       Impact factor: 4.668

3.  The financial impact of Denmark's decision to restrict the use of high-osmolar contrast media in intravascular radiographic procedures.

Authors:  H S Thomsen; J W Archer; L Schiermer; P W Radensky
Journal:  Eur Radiol       Date:  1998       Impact factor: 5.315

4.  Gadolinium contrast media are more nephrotoxic than iodine media. The importance of osmolality in direct renal artery injections.

Authors:  Barbara Elmståhl; Ulf Nyman; Peter Leander; Chun-Ming Chai; Klaes Golman; Jonas Björk; Torsten Almén
Journal:  Eur Radiol       Date:  2006-08-05       Impact factor: 5.315

5.  Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine.

Authors:  M Tepel; M van der Giet; C Schwarzfeld; U Laufer; D Liermann; W Zidek
Journal:  N Engl J Med       Date:  2000-07-20       Impact factor: 91.245

Review 6.  Prevention of generalized reactions to contrast media: a consensus report and guidelines.

Authors:  S K Morcos; H S Thomsen; J A Webb
Journal:  Eur Radiol       Date:  2001       Impact factor: 5.315

Review 7.  Contrast-medium-induced nephropathy: is there a new consensus? A review of published guidelines.

Authors:  Henrik S Thomsen; Sameh K Morcos
Journal:  Eur Radiol       Date:  2006-05-04       Impact factor: 5.315

8.  Nephrotoxic effects in high-risk patients undergoing angiography.

Authors:  Peter Aspelin; Pierre Aubry; Sven-Göran Fransson; Ruth Strasser; Roland Willenbrock; Knut Joachim Berg
Journal:  N Engl J Med       Date:  2003-02-06       Impact factor: 91.245

9.  Comparison of Gd(DTPA-BMA) (Omniscan) versus Gd(HP-DO3A) (ProHance) relative to gadolinium retention in human bone tissue by inductively coupled plasma mass spectroscopy.

Authors:  Gregory W White; Wendell A Gibby; Michael F Tweedle
Journal:  Invest Radiol       Date:  2006-03       Impact factor: 6.016

10.  Risk of contrast-medium-induced nephropathy in high-risk patients undergoing MDCT--a pooled analysis of two randomized trials.

Authors:  Henrik S Thomsen; Sameh K Morcos
Journal:  Eur Radiol       Date:  2008-11-11       Impact factor: 5.315

View more
  4 in total

1.  MRI of colorectal cancer liver metastases: comparison of orally administered manganese with intravenously administered gadobenate dimeglumine.

Authors:  Torkel B Brismar; Nikolaos Kartalis; Christian Kylander; Nils Albiin
Journal:  Eur Radiol       Date:  2011-09-28       Impact factor: 5.315

2.  Significant differences when using MDRD for GFR estimation compared to radionuclide measured clearance.

Authors:  A J Craig; A Britten; S D Heenan; A G Irwin
Journal:  Eur Radiol       Date:  2011-05-21       Impact factor: 5.315

3.  Comparison of the safety of seven iodinated contrast media.

Authors:  Jong-Mi Seong; Nam-Kyong Choi; Joongyub Lee; Yoosoo Chang; Ye-Jee Kim; Bo Ram Yang; Xue-Mei Jin; Ju-Young Kim; Byung-Joo Park
Journal:  J Korean Med Sci       Date:  2013-11-26       Impact factor: 2.153

Review 4.  PET/MR: a paradigm shift.

Authors:  Florian C Gaertner; Sebastian Fürst; Markus Schwaiger
Journal:  Cancer Imaging       Date:  2013-02-27       Impact factor: 3.909

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.